Israel By The Numbers at 60

Israeli Industry
Israel is a leader in water technology, pharmaceuticals and green technology, in spite of a near-constant threat of war. CNBC's Carl Quintanilla reports.
  • Inside Teva     Wednesday, 7 May 2008 | 7:02 AM ET

    NBC's Tel Aviv bureau chief Martin Fletcher gets unprecedented access to drug-maker Teva, an Israeli company with a market cap of $36 billion.

  • Israel By The Numbers at 60 Sunday, 29 Jan 2012 | 8:45 PM ET

    Israel At 60 * News * Special Report

  • Web Extra: Everyday Life     Monday, 5 May 2008 | 12:00 AM ET

    CNBC's Carl Quintanilla describes what it's like to work for a company that's vulnerable to rocket attacks.

  • Web Extra: Up in the Air     Monday, 5 May 2008 | 12:00 AM ET

    CNBC's Carl Quintanilla heads south to look at Israeli businesses booming in spite of the near-constant state of economic and political strife.

  • Web Extra: Full Interview with Dafna Berezovski     Wednesday, 7 May 2008 | 7:05 AM ET

    Israeli car company A Better Place wants to change how the world drives. Dafna Berezovski, the company's sales and marketing manager, explains how.

  • Sell a Car Like a Cell Phone@f0 Wednesday, 7 May 2008 | 7:16 AM ET

    Car companies, oil and gas companies have vowed to clean-up the air.  But an Israeli investor is actually doing something. 

  • Leading the World in Water Wednesday, 7 May 2008 | 7:18 AM ET

    Israel has become known for it's high-tech economy.  But this small desert nation surrounded by often hostile neighbors is working on what it hopes will be it's next wave of success: water.

  • Sderot, Israel     Wednesday, 7 May 2008 | 7:01 AM ET

    CNBC's Carl Quintanilla goes to Sderot, Israel, a town full of industry in spite of being constantly under siege.

  • The Pros' Picks Wednesday, 7 May 2008 | 1:20 PM ET

    As the Dow, Nasdaq and S&P slide into negative territory, CNBC asked the experts how to bolster your investments.

  • Little-Known Investing Gems Wednesday, 7 May 2008 | 12:28 PM ET

    Haim Israel of Merrill Lynch in Jerusalem has some ideas about smaller Israeli companies that might have escaped the attention of U.S. investors.


  Price   Change %Change

Most Popular Video

Wednesday, 23 Apr 2014 | 7:33 AM ET

J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, explains why he decided to pursue Allergan and shares his R&D business model, with CNBC's Kate Kelly. This year we are launching 19 products in the United States, says Pearson.

Wednesday, 23 Apr 2014 | 6:13 AM ET

Chris Caso, Susquehanna Financial Group analyst, shares his outlook on Apple in the second half. Apple needs to show shareholders the next new thing, says Caso.

Wednesday, 23 Apr 2014 | 4:10 AM ET

Fraser Howie, director at Newedge Singapore, says the PMI data reveals China is "in a bit of a rut" and that the government has a "horrible problem" as it can't bring out too much stimulus.